Danaher Co. (NYSE:DHR) has been given a consensus rating of “Buy” by the fourteen research firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $131.83.
Several analysts recently issued reports on DHR shares. Needham & Company LLC reaffirmed a “buy” rating and set a $150.00 price objective (up previously from $135.00) on shares of Veeva Systems in a research note on Wednesday, April 17th. Zacks Investment Research cut shares of GALP ENERGIA SG/ADR from a “hold” rating to a “sell” rating in a research note on Monday, May 6th. Janney Montgomery Scott upped their price objective on shares of Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research note on Wednesday, April 17th. Piper Jaffray Companies set a $29.00 price objective on shares of Bausch Health Companies and gave the company a “buy” rating in a research note on Tuesday, June 11th. Finally, Wolfe Research initiated coverage on shares of Waters in a report on Thursday, May 30th. They issued an “underperform” rating on the stock.
NYSE DHR traded down $2.68 during trading hours on Tuesday, hitting $140.03. 4,283,799 shares of the company’s stock traded hands, compared to its average volume of 2,026,682. Danaher has a 52-week low of $94.59 and a 52-week high of $145.50. The company has a market cap of $100.25 billion, a P/E ratio of 30.98, a PEG ratio of 2.70 and a beta of 0.96. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average is $139.01.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter in the prior year, the company earned $0.99 EPS. Danaher’s revenue was up 3.9% compared to the same quarter last year. On average, equities research analysts predict that Danaher will post 4.77 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.17 dividend. The ex-dividend date is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.49%. Danaher’s payout ratio is 15.04%.
In other news, Director Donald J. Ehrlich sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $132.95, for a total value of $664,750.00. Following the transaction, the director now directly owns 100,603 shares in the company, valued at approximately $13,375,168.85. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $131.30, for a total transaction of $24,143,181.40. Following the completion of the transaction, the chief executive officer now owns 302,377 shares in the company, valued at $39,702,100.10. The disclosure for this sale can be found here. Insiders sold a total of 453,448 shares of company stock worth $59,724,640 over the last quarter. 11.40% of the stock is currently owned by company insiders.
Hedge funds have recently modified their holdings of the company. State of Wisconsin Investment Board lifted its holdings in shares of Danaher by 12.9% in the 1st quarter. State of Wisconsin Investment Board now owns 692,865 shares of the conglomerate’s stock worth $91,472,000 after acquiring an additional 79,287 shares during the last quarter. Canton Hathaway LLC lifted its holdings in shares of Danaher by 8.7% in the 1st quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock worth $1,701,000 after acquiring an additional 1,036 shares during the last quarter. Abacus Planning Group Inc. lifted its holdings in shares of Danaher by 52.3% in the 4th quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock worth $225,000 after acquiring an additional 3,428 shares during the last quarter. Municipal Employees Retirement System of Michigan acquired a new position in shares of Danaher in the 4th quarter worth approximately $1,705,000. Finally, IHT Wealth Management LLC lifted its holdings in shares of Danaher by 5.1% in the 4th quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock worth $209,000 after acquiring an additional 98 shares during the last quarter. Hedge funds and other institutional investors own 78.82% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.